NNC0215-0384

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

InflammationRheumatoid Arthritis

Phase 1

First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis

CompletedNCT01611688

Novo Nordisk A/SInflammation, Rheumatoid Arthritis

Start: 2012-06-04End: 2013-06-17Updated: 2017-02-27

A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis

CompletedNCT01955603

Novo Nordisk A/SInflammation, Rheumatoid Arthritis

Start: 2013-09-30End: 2014-10-31Updated: 2014-10-15